Pituitary Adenoma: SSTR2 rs2236750, SSTR5 rs34037914, and AIP rs267606574 Genetic Variants, Serum Levels, and Ki-67 Labeling Index Associations

Medicina (Kaunas). 2024 Aug 1;60(8):1252. doi: 10.3390/medicina60081252.

Abstract

Background and Objectives: This study explores the complex pathogenesis of pituitary adenomas (PAs), prevalent intracranial tumors in the pituitary gland. Despite their generally benign nature, PAs exhibit a diverse clinical spectrum involving hormone hypersecretion and varying invasiveness, hinting at multifaceted molecular mechanisms and abnormalities in tumorigenesis and gene regulation. Materials and Methods: The investigation focuses on the Ki-67 labeling index, SSTR2 rs2236750, SSTR5 rs34037914, and AIP rs267606574 polymorphisms, alongside serum levels of SSTR2, SSTR5, and AIP, to discern their association with PAs. The Ki-67 labeling index was assessed using immunohistochemical analysis with the monoclonal antibody clone SP6, representing the percentage of tumor cells showing positive staining. Genotyping was performed via real-time polymerase chain reaction, and serum levels were analyzed using ELISA. The study included 128 PA patients and 272 reference group subjects. Results: The results derived from binary logistic regression analysis revealed an intriguing correlation between the SSTR2 rs2236750 AG genotype and approximately a 1.6-fold increased likelihood of PA occurrence. When analyzing SSTR5 rs34037914, statistically significant differences were found between Micro-PA and the reference group (p = 0.022). Additionally, the SSTR5 rs34037914 TT genotype, compared with CC + CT, under the most robust genetic model (selected based on the lowest AIC value), was associated with a 12-fold increased odds of Micro-PA occurrence. However, it is noteworthy that after applying Bonferroni correction, these findings did not retain statistical significance. Conclusions: Consequently, while this study hinted at a potential link between SSTR2 rs2236750 and pituitary adenoma development, as well as a potential link between SSTR5 rs34037914 and Micro-PA development, it underscored the need for further analysis involving a larger cohort to robustly validate these findings.

Keywords: AIP rs267606574 polymorphisms; Ki-67 labeling index; SSTR2 rs2236750; SSTR5 rs34037914; pituitary adenoma; serum levels.

MeSH terms

  • Adenoma* / blood
  • Adenoma* / genetics
  • Adult
  • Aged
  • Female
  • Genetic Variation
  • Genotype
  • Humans
  • Intracellular Signaling Peptides and Proteins / genetics
  • Ki-67 Antigen* / analysis
  • Ki-67 Antigen* / genetics
  • Male
  • Middle Aged
  • Pituitary Neoplasms* / blood
  • Pituitary Neoplasms* / genetics
  • Receptors, Somatostatin* / analysis
  • Receptors, Somatostatin* / genetics

Substances

  • Receptors, Somatostatin
  • somatostatin receptor 5
  • Ki-67 Antigen
  • SSTR2 protein, human
  • Intracellular Signaling Peptides and Proteins

Grants and funding

This study was funded by the Research Council of Lithuania, Agreement No. S-LLT-23-2.